XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Debt securities, available for sale:          
Amortized Cost $ 667.8   $ 667.8   $ 210.7
Gross Unrealized Gains 0.5   0.5   0.0
Gross Unrealized Losses 0.0   0.0   (0.1)
Estimated Market Value 668.3   668.3   210.6
Total marketable securities          
Cost or Amortized Cost         212.7
Gross Unrealized Gains         36.0
Gross Unrealized Losses         (0.1)
Estimated Market Value 668.3   668.3   248.6
Equity Securities Net Gain          
Net gains recognized during the period on equity securities 0.0 $ 42.7 (4.2) $ 50.1  
U.S. government agencies          
Debt securities, available for sale:          
Amortized Cost 531.2   531.2   173.2
Gross Unrealized Gains 0.4   0.4   0.0
Gross Unrealized Losses 0.0   0.0   (0.1)
Estimated Market Value 531.6   531.6   173.1
Commercial paper          
Debt securities, available for sale:          
Amortized Cost 98.8   98.8   36.2
Gross Unrealized Gains 0.1   0.1   0.0
Gross Unrealized Losses 0.0   0.0   0.0
Estimated Market Value 98.9   98.9   36.2
Corporate debt          
Debt securities, available for sale:          
Amortized Cost 37.8   37.8   1.3
Gross Unrealized Gains 0.0   0.0   0.0
Gross Unrealized Losses 0.0   0.0   0.0
Estimated Market Value $ 37.8   $ 37.8   1.3
Equity investment in Tandem Diabetes Care, Inc          
Equity investment in Tandem Diabetes Care, Inc.          
Cost or Amortized Cost         2.0
Gross Unrealized Gains         36.0
Gross Unrealized Losses         0.0
Estimated Market Value         $ 38.0